Dr Robert Scoffin, CEO of Cresset, awarded Fellowship of Royal Society of Chemistry


29-03-2016

Cresset, innovative provider of software and discovery services for small molecule discovery and design, is pleased to announce that Cresset’s CEO, Dr Robert Scoffin, has been awarded a Fellowship of the Royal Society of Chemistry.

 

Dr Robert Scoffin FRSC, is an expert in the fields of molecular modeling and cheminformatics. He joined Cresset as CEO in 2010. His previous roles include CEO of Amedis and VP, Europe at CambridgeSoft. He also heads up Re-Pharm, an early stage discovery company which uses Cresset software to assess compounds for repurposing. His DPhil is in Chemistry from the University of Oxford.

Dr Scoffin joins Cresset’s CSO, Dr Mark Mackey, as a Fellow of the RSC.
 
 
About Cresset
Cresset’s software and contract research services are used by chemists from the world’s leading research organizations. Our patented methods deliver novel, realistic results for discovering, designing and optimizing the best small molecules in industry sectors including: agrochemicals, fine chemicals, flavor, fragrance and pharmaceuticals. www.cresset-group.com


Contact
 
Sue Peffer, Marketing Manager, news@cresset-group.com, +44 (0)1223 858890

______________________________________

 

Computational solutions for drug discovery

Cresset